Ildong Holdings Co., Ltd. (KRX:000230)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,650
-310 (-2.22%)
At close: Nov 25, 2025
93.07%
Market Cap154.59B
Revenue (ttm)620.44B
Net Income (ttm)67.54B
Shares Out11.29M
EPS (ttm)5,327.40
PE Ratio2.67
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume230,438
Average Volume1,324,679
Open14,090
Previous Close13,960
Day's Range13,400 - 14,570
52-Week Range5,470 - 16,370
Beta0.69
RSI60.21
Earnings DateNov 6, 2025

About Ildong Holdings

Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally. It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product. It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics. In addition, ... [Read more]

Sector Healthcare
Founded 1941
Employees 72
Stock Exchange Korea Stock Exchange
Ticker Symbol 000230
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.